biote (US:BTMD) — Company Overview, News & Financial Data

biote logo
BTMDbiote
Trade BTMD now
biote primary media

About biote

Biote (NASDAQ:BTMD) specializes in hormone optimization and personalized healthcare solutions, focusing on addressing hormonal imbalances through bio-identical hormone replacement therapy (BHRT). With a patient-centered approach, Biote aims to enhance the quality of life for individuals by offering tailored treatment plans that address a wide range of hormonal issues. Their projects extend into research and development of new protocols for hormone optimization, aiming to set new standards in personalized medicine. Biote's objectives are to expand its market reach, continuously improve patient outcomes through innovative therapies, and contribute to the broader understanding of hormone-related health conditions.

What is BTMD known for?

Snapshot

Public US
Ownership
2012
Year founded
194
Employees
Irving, United States
Head office
Loading Map...

Operations

All Locations
Irving, US

Products and/or services of biote

  • Hormone optimization therapies, focusing on balancing hormones to improve patient health and wellbeing.
  • Bioidentical hormone replacement therapy (BHRT) pellets, a natural approach to addressing hormone imbalances.
  • Personalized hormone optimization plans, tailored to individual patient needs for comprehensive healthcare.
  • Nutraceuticals line, offering supplements to support hormone health and overall wellness.
  • Educational resources for practitioners, enhancing understanding of hormone optimization and BHRT.
  • Partnership programs with healthcare providers, expanding access to hormone optimization treatments.

biote executive team

  • Mr. Robert C. PetersonCFO and Chief Business Officer
  • Mr. Bret ChristensenCEO & Director
  • Mr. John J. OlsenChief Information Officer
  • Ms. Mary Elizabeth ConlonVP of Business Development, General Counsel & Corporate Secretary
  • Mr. Joel PickeringChief Marketing Officer
  • Mr. Richard Kevin KeyChief Digital Officer
  • Mr. Jade BeutlerHead of Nutraceuticals
  • Dr. Cory Rice D.O.Chief Clinical Advisor & Member of Medical Advisory Board
  • Mr. Joey LopesSVP of Strategy & Commercial Operations

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.